AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Cash Flow ABMD Quote ABIOMED Inc

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 20142015201620172018
NetIncome 7 114 38 52 112
Depreciation 3 3 3 0 0
DeferredIncomeT 1 -87 22 26 43
StockBasedCompe 11 17 29 33 40
AccountsReceiva -1 -8 -11 -12 -15
InventoryCS -1 -7 -11 -12 -16
AccountsPayable 0 3 -3 8 4
OtherWorkingCap 1 2 2 2 4
OtherNonCashIte 0 0 -3 -10 1
NetCashProvided 23 43 77 115 193
InvestmentsInPP -3 -5 -16 -50 -56
AcquisitionsNet 0 -16 0 0 0
PurchasesOfInve -88 -101 -262 -281 -332
SalesMaturities 68 72 220 205 207
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI -22 -50 -58 -126 -181
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 0 -1
CommonStockIssu 0 0 0 0 0
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 10 9 4 -8 -9
NetCashProvided 10 10 7 4 -9
NetChangeInCash 11 1 26 -9 4
CashAtBeginning 9 21 22 48 39
CashAtEndOfPeri 21 22 48 39 43
ABIOMED Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ABIOMED Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.